Genotype distribution in chronic hepatitis C patients in Greece
- PMID: 22372362
Genotype distribution in chronic hepatitis C patients in Greece
Abstract
Background: Hepatitis C is a major public health problem. HCV infection contributes to progressive liver disease, cirrhosis, and hepatocellular carcinoma. HCV has high genetic heterogeneity and is classified into various genotypes and subtypes. Regional differences exist in their distribution. The aim of this study was to investigate the relative frequency of HCV genotypes in Greek patients with chronic infection.
Methods: We evaluated 82 patients with chronic HCV infection, both males and females, belonging to different risk groups. We performed viral load measurement and HCV genotyping in all specimens.
Results: HCV genotype 3 was the most prevalent (41.5%) followed by genotype 1 (34.1%), 2 (12.2%), 4 (10.9%), and 5 (1.2%). Genotype 6 was not detected in any patient. Most prevalent subtypes were 3a (32.9%), 1b (26.8%), and 2a (6.1%). Fourteen subjects revealed mixed infections within types. There were no cases with mixed infections across types.
Conclusions: Our data indicate that genotypes 3a and 1b are the most prevalent in Greek patients. Genotype 3a is predominant in younger patients and also in male patients. Moreover, HCV genotype distribution is in continuous temporal change in Greece.
Similar articles
-
[Investigation of the relationship between hepatitis c virus (HCV) genotypes with HCV-RNA and alanine aminotransferase levels in chronic hepatitis c patients].Mikrobiyol Bul. 2010 Jan;44(1):111-5. Mikrobiyol Bul. 2010. PMID: 20455406 Turkish.
-
Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B.Am J Gastroenterol. 1999 Oct;94(10):3015-9. doi: 10.1111/j.1572-0241.1999.01456.x. Am J Gastroenterol. 1999. PMID: 10520862
-
[Genotypes of hepatitis C virus: their relationship with risk factors, the severity of liver disease, and the serologic response].Med Clin (Barc). 1998 May 23;110(18):681-6. Med Clin (Barc). 1998. PMID: 9656219 Spanish.
-
Distribution of hepatitis C virus genotypes in Croatia--a 10 year retrospective study of four geographic regions.Coll Antropol. 2006 Dec;30 Suppl 2:139-43. Coll Antropol. 2006. PMID: 17508487
-
[Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].Mikrobiyol Bul. 2010 Oct;44(4):647-50. Mikrobiyol Bul. 2010. PMID: 21063977 Turkish.
Cited by
-
Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Mediators Inflamm. 2015;2015:287640. doi: 10.1155/2015/287640. Epub 2015 Apr 19. Mediators Inflamm. 2015. PMID: 25969625 Free PMC article. Review.
-
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+).Hepatology. 2016 May;63(5):1430-41. doi: 10.1002/hep.28473. Epub 2016 Mar 4. Hepatology. 2016. PMID: 26822022 Free PMC article. Clinical Trial.
-
Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern Italy.PLoS One. 2019 Feb 20;14(2):e0212033. doi: 10.1371/journal.pone.0212033. eCollection 2019. PLoS One. 2019. PMID: 30785909 Free PMC article.
-
Epidemiology of hepatitis C in Greece.World J Gastroenterol. 2016 Sep 28;22(36):8094-102. doi: 10.3748/wjg.v22.i36.8094. World J Gastroenterol. 2016. PMID: 27688651 Free PMC article. Review.
-
Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.Clin Exp Med. 2015 Aug;15(3):293-302. doi: 10.1007/s10238-014-0297-2. Epub 2014 Jun 13. Clin Exp Med. 2015. PMID: 24925642